Apriem Advisors’s Chimerix, Inc. CMRX Stock Holding History

Apriem Advisors’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,000	Closed	-$10K	–	399
2018 Q2	$10K	Buy	+2,000	New	+$9.56K	﹤0.01%	432
2017 Q2	–	Sell	-2,000	Closed	-$13K	–	573
2017 Q1	$13K	Hold	2,000	–	–	﹤0.01%	395
2016 Q4	$9K	Hold	2,000	–	–	﹤0.01%	453
2016 Q3	$11K	Hold	2,000	–	–	﹤0.01%	401
2016 Q2	$8K	Hold	2,000	–	–	﹤0.01%	436
2016 Q1	$10K	Hold	2,000	–	–	﹤0.01%	387
2015 Q4	$18K	Buy	+2,000	New	+$72K	0.01%	318

Other funds holding CMRX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Apriem Advisors's CMRX Position: Q3 2018 in Review

Apriem Advisors sold out of Chimerix, Inc. (CMRX) in Q3 2018, closing a stake of 2,000 shares — an estimated $10K sold.

Apriem Advisors first reported a position in CMRX in Q4 2015 and held it in 7 quarters. The position peaked at $18K in Q4 2015. 89 funds tracked by Wall St. Rank hold CMRX as of Q3 2018.

Apriem Advisors reported no remaining Chimerix, Inc. position as of Q3 2018 after selling out during the quarter.
Apriem Advisors sold 2,000 Chimerix, Inc. shares in Q3 2018, an estimated $10K.
Apriem Advisors first reported a position in Chimerix, Inc. in Q4 2015 and held it in 7 quarters.
Apriem Advisors's Chimerix, Inc. position peaked at $18K in Q4 2015.
89 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2018.

Based on Apriem Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.